These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 3486769
21. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP. Kindt MV, Youngster SK, Sonsalla PK, Duvoisin RC, Heikkila RE. Eur J Pharmacol; 1988 Feb 09; 146(2-3):313-8. PubMed ID: 3131149 [Abstract] [Full Text] [Related]
22. Protection and potentiation of MPTP-induced toxicity by cytochrome P-450 inhibitors and inducer: in vitro studies with brain slices. Pai KS, Ravindranath V. Brain Res; 1991 Aug 02; 555(2):239-44. PubMed ID: 1933335 [Abstract] [Full Text] [Related]
23. Effects of the parkinsonism-inducing neurotoxin MPTP and its metabolite MPP+ on sympathetic adrenergic nerves in mouse iris and atrium. Luthman J, Jonsson G. Med Biol; 1986 Aug 02; 64(2-3):95-102. PubMed ID: 3489145 [Abstract] [Full Text] [Related]
24. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Fuller RW, Hemrick-Luecke SK, Perry KW. J Pharmacol Exp Ther; 1988 Nov 02; 247(2):531-5. PubMed ID: 3141609 [Abstract] [Full Text] [Related]
25. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH. Proc Natl Acad Sci U S A; 1985 Apr 02; 82(7):2173-7. PubMed ID: 3872460 [Abstract] [Full Text] [Related]
26. Intracerebroventricular administration of 1-methyl-4-phenylpyridinium ion in mice: effects of simultaneously administered nomifensine, deprenyl, and 1-t-butyl-4,4-diphenylpiperidine. Mihatsch W, Russ H, Przuntek H. J Neural Transm; 1988 Apr 02; 71(3):177-88. PubMed ID: 3128644 [Abstract] [Full Text] [Related]
27. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+. Shen RS, Abell CW, Gessner W, Brossi A. FEBS Lett; 1985 Sep 23; 189(2):225-30. PubMed ID: 3876242 [Abstract] [Full Text] [Related]
28. Role of nitric oxide synthase against MPTP neurotoxicity in mice. Kurosaki R, Muramatsu Y, Michimata M, Matsubara M, Kato H, Imai Y, Itoyama Y, Araki T. Neurol Res; 2002 Oct 23; 24(7):655-62. PubMed ID: 12392201 [Abstract] [Full Text] [Related]
29. Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP. Melamed E, Rosenthal J, Cohen O, Globus M, Uzzan A. Eur J Pharmacol; 1985 Oct 08; 116(1-2):179-81. PubMed ID: 3876943 [Abstract] [Full Text] [Related]
30. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites. Itzhak Y, Mash D, Zhang SH, Stein I. Mol Pharmacol; 1991 Mar 08; 39(3):385-93. PubMed ID: 1848660 [Abstract] [Full Text] [Related]
31. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons. Johannessen JN. Neurotoxicology; 1991 Mar 08; 12(2):285-302. PubMed ID: 1956587 [Abstract] [Full Text] [Related]
32. Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity. Kalaria RN, Mitchell MJ, Harik SI. Proc Natl Acad Sci U S A; 1987 May 08; 84(10):3521-5. PubMed ID: 3495000 [Abstract] [Full Text] [Related]
33. 2-deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse brain. Chan P, Langston JW, Irwin I, DeLanney LE, Di Monte DA. J Neurochem; 1993 Aug 08; 61(2):610-6. PubMed ID: 8336145 [Abstract] [Full Text] [Related]
34. Localization in rat brain of binding sites for parkinsonian toxin MPTP: similarities with [3H]pargyline binding to monoamine oxidase. Rainbow TC, Parsons B, Wieczorek CM, Manaker S. Brain Res; 1985 Mar 25; 330(2):337-42. PubMed ID: 3872699 [Abstract] [Full Text] [Related]
35. Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice. Sundström E, Strömberg I, Tsutsumi T, Olson L, Jonsson G. Brain Res; 1987 Mar 03; 405(1):26-38. PubMed ID: 2882814 [Abstract] [Full Text] [Related]
36. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Fuller RW, Hemrick-Luecke SK. J Pharmacol Exp Ther; 1985 Mar 03; 232(3):696-701. PubMed ID: 3871853 [Abstract] [Full Text] [Related]
37. Primate-rodent 3H-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro. Corsini GU, Pintus S, Bocchetta A, Piccardi MP, Del Zompo M. J Neural Transm Suppl; 1986 Mar 03; 22():55-60. PubMed ID: 3097260 [Abstract] [Full Text] [Related]
38. Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA. Melamed E, Rosenthal J, Globus M, Cohen O, Uzzan A. Brain Res; 1985 Sep 09; 342(2):401-4. PubMed ID: 3876139 [Abstract] [Full Text] [Related]
39. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs. Youngster SK, Sonsalla PK, Sieber BA, Heikkila RE. J Pharmacol Exp Ther; 1989 Jun 09; 249(3):820-8. PubMed ID: 2786564 [Abstract] [Full Text] [Related]
40. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes. Di Monte D, Jewell SA, Ekström G, Sandy MS, Smith MT. Biochem Biophys Res Commun; 1986 May 29; 137(1):310-5. PubMed ID: 3487319 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]